Simplex Trading’s Spark Therapeutics, Inc. Common Stock ONCE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q3 | – | Sell |
-221
| Closed | -$22.1K | – | 8258 |
|
|
2019
Q2 | $22K | Sell |
221
-43,038
| -99% | -$4.64M | ﹤0.01% | 5553 |
|
|
2019
Q1 | $4.93M | Buy |
43,259
+26,327
| +155% | +$1.94M | 0.01% | 689 |
|
|
2018
Q4 | $662K | Buy |
16,932
+6,426
| +61% | +$279K | ﹤0.01% | 1976 |
|
|
2018
Q3 | $573K | Buy |
+10,506
| New | +$718K | ﹤0.01% | 2487 |
|
|
2018
Q2 | – | Sell |
-6,106
| Closed | -$471K | – | 8186 |
|
|
2018
Q1 | $406K | Sell |
6,106
-10,490
| -63% | -$606K | 0.02% | 826 |
|
|
2017
Q4 | $853K | Buy |
+16,596
| New | +$1.19M | 0.04% | 461 |
|
|
2017
Q2 | – | Sell |
-3,986
| Closed | -$223K | – | 7187 |
|
|
2017
Q1 | $212K | Buy |
3,986
+3,857
| +2,990% | +$229K | 0.01% | 1176 |
|
|
2016
Q4 | $6K | Sell |
129
-546
| -81% | -$29.2K | ﹤0.01% | 4268 |
|
|
2016
Q3 | $40K | Buy |
+675
| New | +$38.9K | ﹤0.01% | 2310 |
|
|
2016
Q2 | – | Sell |
-607
| Closed | -$25.9K | – | 6777 |
|
|
2016
Q1 | $17K | Sell |
607
-3,383
| -85% | -$107K | ﹤0.01% | 2972 |
|
|
2015
Q4 | $180K | Buy |
+3,990
| New | +$209K | 0.01% | 947 |
|
Simplex Trading's ONCE Position: Q3 2019 in Review
Simplex Trading sold out of Spark Therapeutics, Inc. Common Stock (ONCE) in Q3 2019, closing a stake of 221 shares — an estimated $22.1K sold.
Simplex Trading first reported a position in ONCE in Q4 2015 and held it in 11 quarters. The position peaked at $4.93M in Q1 2019. 184 funds tracked by Wall St. Rank hold ONCE as of Q3 2019.
- Simplex Trading reported no remaining Spark Therapeutics, Inc. Common Stock position as of Q3 2019 after selling out during the quarter.
- Simplex Trading sold 221 Spark Therapeutics, Inc. Common Stock shares in Q3 2019, an estimated $22.1K.
- Simplex Trading first reported a position in Spark Therapeutics, Inc. Common Stock in Q4 2015 and held it in 11 quarters.
- Simplex Trading's Spark Therapeutics, Inc. Common Stock position peaked at $4.93M in Q1 2019.
- 184 funds tracked by Wall St. Rank held Spark Therapeutics, Inc. Common Stock as of Q3 2019.
Based on Simplex Trading's 13F filing for Q3 2019, filed 15 Oct 2019.